Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor

Sunday, November 21, 2021 1 min read

Key Takeaway: Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor